연구성과로 돌아가기

2022 연구자 정보 (909 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kang, Sungbong
(Kang, S)
Soongsil Univ, Dept Bioinformat & Life Sci, Seoul, South Korea
0000-0002-8845-7130
kang, Sungbong
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients SCIE 65.2 HEMATOLOGY;ONCOLOGY ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
Kim, Da-Jung
(Kim, DJ)
Kosin Univ, Gospel Hosp, Busan, South Korea

[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) SCIE 65.2 HEMATOLOGY;ONCOLOGY
Kim, Dennis Dong Hwan
(Kim, DDH)
교신저자 Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
Univ Toronto, Princess Margaret Canc Ctr, 610 Univ Ave, OPG Rm 6-222, Toronto, ON M5G 2M9, Canada
Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
Univ Toronto, Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
AAH-8499-2019
Kim, Dennis

Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia
[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms
[JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
SCIE 21.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca;
f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Kim, Hawk
(Kim, H)
Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea
Gachon Univ, Gil Med Ctr, Div Hematol, Med Ctr,Coll Med, Incheon, South Korea
Gachon Univ, Gil Med Ctr, Div Hematol, Coll Med, Incheon, South Korea
B-9921-2013
Kim, Tae

[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
SCIE
ESCI
65.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY
ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
jh21.jang@samsung.com;ssysmc@snu.ac.kr;
inkyung.joo@novartis.com;D.W.K.dwkim@eulji.ac.kr;dwkim@eulji.ac.kr;
Kim, Hoon-Gu
(Kim, HG)
Gyeongsang Natl Univ, Gyeongsang Inst Hlth Sci, Dept Internal Med, Coll Med, Chang Won, South Korea
Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea
Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Gyeongsang Inst Hlth Sci, Chang Won, South Korea


[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
SCIE
ESCI
65.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY
ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
inkyung.joo@novartis.com;D.W.K.dwkim@eulji.ac.kr;dwkim@eulji.ac.kr;
Kim, Hyeong-Joon
(Kim, HJ)
Chonnam Natl Univ, Hwasun Hosp, Gwangju, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Hwasun, South Korea


[JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
SCIE 65.2 HEMATOLOGY;ONCOLOGY ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
Kim, Hyeoung-Joon
(Kim, HJ)
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Gwangju, Jeonranam Do, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Sch Med, Hwasun, Jeonranam Do, South Korea
Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Sch Med, Hwasun, Jeonranam Do, South Korea
Chonnam Natl Univ, Genome Res Ctr Hematopoiet Dis, Sch Med, 322 Seoyang Ro, Hwasun 58128, Jeonranam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Hematol Oncol, Hwasun Gun, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Jeollanam Do, South Korea
Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Hwasun Hosp, Jeollanam Do, South Korea
IAP-6721-2023
ABD-3143-2020
Kim, Chang Gon
Kim, Hyung Joon

[JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline
Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia
[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms
[JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
[JCR상위 44.2] Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
[JCR상위 3.2] Prognostic Predictability of 2022 European Leukemianet (ELN) Risk Stratification in the Real World
SCIE 3.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
CELL & TISSUE ENGINEERING;MEDICINE, RESEARCH & EXPERIMENTAL;TRANSPLANTATION
HEMATOLOGY
jhmoon@knu.ac.kr;
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca;
f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
sksohn@knu.ac.kr;jhmoon@knu.ac.kr;
Kim, Ju-Hyung
(Kim, JH)
Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea


[JCR상위 65.2] Clinical impact of time to the best response in relapsed/refractory multiple myeloma patients receiving carfilzomib
[JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline
[JCR상위 44.2] Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
SCIE 44.2 HEMATOLOGY;ONCOLOGY
CELL & TISSUE ENGINEERING;MEDICINE, RESEARCH & EXPERIMENTAL;TRANSPLANTATION
jhmoon@knu.ac.kr;
sksohn@knu.ac.kr;jhmoon@knu.ac.kr;
Kim, Kihyun
(Kim, K)
Samsung Med Ctr, Seoul, South Korea
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
D-5175-2013
Kim, Kihyun
0000-0002-5878-8895
Kim, Kihyun
[JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
[JCR상위 35.1] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study)
[JCR상위 5.7] Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
SCIE 5.7 HEMATOLOGY;ONCOLOGY
ONCOLOGY
drjejung@chonnam.ac.kr;ckmin@catholic.ac.kr;
kihyunkimk@gmail.com;drjejung@chonnam.ac.kr;
Kim, Kyoung Ha
(Kim, KH)
Soonchunhyang Univ, Seoul Hosp, Seoul, South Korea
Soonchunhyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Soonchunhyang Univ, Dept Internal Med, Seoul Hosp, Seoul, South Korea
KGM-1468-2024
Kim, Pyeong Hwa

[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study)
[JCR상위 3.2] Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
SCIE 3.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY
ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
Kim, Mihee
(Kim, M)
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Hwasun Hosp, Gwangju, South Korea
Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun Gun, Jeollanam Do, South Korea
AAH-8499-2019
Kim, Dennis

Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia
[JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
[JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
[JCR상위 3.2] Prognostic Predictability of 2022 European Leukemianet (ELN) Risk Stratification in the Real World
SCIE 3.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
HEMATOLOGY
zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Kim, Min Kyoung
(Kim, MK)
Yeungnam Univ, Med Ctr, Gyongsan, South Korea
Yeungnam Univ, Med Ctr, Daegu, South Korea
Yeungnam Univ, Yeungnam Univ Med Ctr, Coll Med, Dept Internal Med, Daegu, South Korea
Yeungnam Univ, Coll Med, Gyongsan, South Korea
LLK-4732-2024
ACN-6827-2022
GMX-1345-2022
Kim, Il Young
Kim, Min
Lee, Min Young

[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study)
[JCR상위 5.7] Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
[JCR상위 3.2] Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
SCIE
ESCI
3.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY
kihyunkimk@gmail.com;drjejung@chonnam.ac.kr;
inkyung.joo@novartis.com;D.W.K.dwkim@eulji.ac.kr;dwkim@eulji.ac.kr;
Kim, Sangsoo
(Kim, S)
교신저자 Soongsil Univ, Dept Bioinformat & Life Sci, Seoul, South Korea

[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients SCIE 65.2 HEMATOLOGY;ONCOLOGY ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr;
Kim, TaeHyung
(Kim, T)
제1저자 Univ Toronto, Dept Comp Sci, Toronto, ON, Canada
Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada
Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
O-4252-2015
Kim, Tae

[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms
[JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
SCIE 21.2 HEMATOLOGY;ONCOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca;
f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Lee, Hyun Jeong
(Lee, HJ)
Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Seoul, South Korea JFA-4725-2023
Lee, Jeong

[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) SCIE 65.2 HEMATOLOGY;ONCOLOGY
페이지 이동: